Trial reportJournal of neuroengineering and rehabilitation2026
γ-transcranial alternating current stimulation improves upper-limb motor function in stroke patients and modulates oscillatory imbalance: a pilot randomized controlled trial.
Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPost-stroke cortical oscillatory activity is frequently disrupted, characterized by increased low-frequency oscillation and reduced high-frequency oscillation, which are associated with stroke severity and motor dysfunction. γ-tACS has the potential to entrain brain oscillations and enhance motor performance in healthy individuals, yet evidence in stroke patients is still limited.
methodsThis randomized, double-blind, sham-controlled pilot study enrolled 42 patients with post-stroke upper-limb motor impairment. Participants were randomly assigned to either the γ-tACS group or the sham-tACS group. High-definition tACS was applied over the M1 hotspot (70 Hz, 2 mA peak-to-peak, 20 min/session) for 10 sessions, once daily, in addition to conventional rehabilitation. The primary outcome was the Fugl-Meyer Assessment-Upper Extremity (FMA-UE). Secondary outcomes included the Modified Barthel Index (MBI) and resting-state EEG measures, including spectral power, power-ratio indices, and functional connectivity.
resultsA total of 42 participants were included in this trial (γ-tACS, n = 21; sham-tACS, n = 21), and the baseline characteristics were comparable between groups. FMA-UE improved in both groups, but the improvement was greater in γ-tACS group (ΔFMA-UE = 4.64 ± 4.55, P = 0.039, 95%CI=[0.154, 5.799]), whereas between-group differences in MBI improvement were not significant. Baseline EEG showed ipsilesional-contralesional asymmetry, with higher delta power, lower alpha power and elevated delta alpha ratio (DAR), delta beta ratio (DBR), and (delta+theta)/(alpha+beta) ratio (DTABR) on the ipsilesional side. After treatment, γ-tACS reduced ipsilesional delta power and lowered DBR and DTABR. Greater reductions in delta power and DTABR were associated with greater improvement in FMA-UE. In addition, γ-tACS increased ipsilesional beta-band connectivity (FC3-C3 wPLI), and this increase was also associated with motor improvement.
conclusionsCompared with sham-tACS, γ-tACS applied over the ipsilesional M1 improved upper-limb motor function in patients with stroke. These clinical improvements were accompanied by restored oscillatory balance and enhanced network connectivity. Quantitative EEG parameters may serve as useful biomarkers for tracking neurophysiological changes and treatment response during stroke recovery. Trial registration This study was registered in the Chinese Clinical Trial Registry (ChiCTR2300074898, date of registration: 2023/08/18).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.